U.S. investments, and rhetoric, help AstraZeneca seal drug deal with Trump
Tomas Kauer - News Writer and Moderator 
Deal to lower drug costs for Americans and shield the drugmaker from import tariffs was the culmination of efforts stretching back to November last year, sources say.
